Willingness to Pay for a Quality-adjusted Life Year
By R. Hirth, Michael E. Chernew, E. Miller, A. Fendrick, William G. Weissert. Medical decision making, 2000
941 citations recorded by the source corpus.
Subfields: Economics and Econometrics
View Paper: https://www.semanticscholar.org/paper/6bbcdc73b51225c7dca67aad96592b463a1a8447
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Dmitry Taubinsky
- Benjamin B. Lockwood
- Hunt Allcott
- Darrell J. Gaskin
- T. Laveist
- P. Richard
- C. Jo
- C. Cattaneo
Citations in the corpus
- Regressive Sin Taxes, with an Application to the Optimal Soda Tax* (2019, methodology): “58 This translates to $105 per person using the commonly used conservative estimate of $50,000 for the value of a QALY (Hirth et al., 2000), corresponding to a marginal health cost of $0.”
- International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2010, background): “(Hirth et al., 2000) If this higher threshold is utilized in analysis, however, almost all the new healthcare technologies are judged to be cost effective.”
- Cost-of-illness studies: concepts, scopes, and methods (2014, methodology): “The WTP approach, usually with higher estimates of the value of life than the HCM attempts to ameliorate these problems.(12) However, this approach is often difficult to implement in COI studies.”
- Osteoporosis in the European Union: medical management, epidemiology and economic burden (2013, background): “Bisphosphonates are generally found to be cost-effective in women with osteoporosis, regardless of whether or not the perspective is societal and if the modelling horizon is lifetime or shorter [106].”
- Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? (2004, background): “” Goldman et al. [42] summarized their assessment of cost-effectiveness of a range of cardiovascular interventions with a recommendation: “At the current time[1996], programs that cost less than about $40,000 per year of life saved, which roughly corresponds to renal dialysis, have been recommended ”
- The Economic Burden of Health Inequalities in the United States (2009, positive): “We valued each year of life loss at $50,000 (Hirth et al. 2000).”